Zepbound® 15 mg is a once-weekly injectable medication for chronic weight management in adults with obesity or overweight-related health conditions. This 15 mg dose is the maximum recommended dose, designed to provide the highest level of weight loss benefits after gradual titration from the starting dose. Zepbound® combines two hormone receptors, GLP-1 and GIP, to effectively suppress appetite, reduce food intake, and support lasting weight management. Each prefilled pen delivers 15 mg of tirzepatide in 0.5 mL and is intended for subcutaneous injection.

Features:

• Maximum Maintenance Dose: 15 mg is the highest recommended dose, offering maximum efficacy for sustained weight loss and appetite control.

• Once-Weekly Dosing: Convenient weekly injection with no mixing or preparation required.

• Prefilled, Ready-to-Use Pens: Each pen is prefilled and designed for easy subcutaneous use without additional dose preparation.

• Dual Hormone Receptor Action: Tirzepatide acts as a GLP-1 and GIP receptor agonist to reduce appetite, enhance satiety, and support long-term weight loss goals.

• 4-Pack for 4 Weeks: The 15 mg dose comes in a pack of 4 pens, providing a full month of therapy at the maximum dose.